Globus Medical to buy neurostim developer Nevro for $250M - Fierce Biotech
The company's full annual accounting is scheduled for February 20. Related. Nevro nabs FDA approval for spinal cord stimulator that uses AI to …
Read the original at Fierce Biotech ↗
- Topics
- Healthcare
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “that uses AI to”